Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Addex Therapeutics (ADXN) Return on Sales: 2022-2025

Historic Return on Sales for Addex Therapeutics (ADXN) over the last 2 years, with Jun 2025 value amounting to 0.01%.

  • Addex Therapeutics' Return on Sales rose 456.00% to 0.01% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.01%, marking a year-over-year increase of 456.00%. This contributed to the annual value of 29.61% for FY2024, which is 3460.00% up from last year.
  • According to the latest figures from Q2 2025, Addex Therapeutics' Return on Sales is 0.01%, which was down 93.23% from 0.16% recorded in Q1 2025.
  • In the past 5 years, Addex Therapeutics' Return on Sales ranged from a high of 1.08% in Q3 2023 and a low of -12.15% during Q4 2024.
  • For the 3-year period, Addex Therapeutics' Return on Sales averaged around -3.40%, with its median value being -3.02% (2023).
  • Per our database at Business Quant, Addex Therapeutics' Return on Sales skyrocketed by 481bps in 2023 and then crashed by 938bps in 2024.
  • Over the past 4 years, Addex Therapeutics' Return on Sales (Quarterly) stood at -7.72% in 2022, then spiked by 481bps to -2.91% in 2023, then slumped by 924bps to -12.15% in 2024, then surged by 456bps to 0.01% in 2025.
  • Its Return on Sales stands at 0.01% for Q2 2025, versus 0.16% for Q1 2025 and -12.15% for Q4 2024.